Methicillin-resistant Staphylococcus aureus (MRSA) eradication in Cystic Fibrosis patients: influence on lung function values

Not Applicable

Completed

• Conditions: Cystic fibrosis - MRSA infection; Nutritional, Metabolic, Endocrine; Cystic fibrosis, unspecified

• Registration Number: ISRCTN69078742
• Lead Sponsor: niversity Hospital Brussels (Universitair Ziekenhuis Brussel [UZ Brussel]) (Belgium)

Brief Summary

2013 results in https://pubmed.ncbi.nlm.nih.gov/23706641/ (added 13/08/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-03
• Study Completion: 2015-06-01
• Last Update Posted: 24 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 11

Inclusion Criteria

1. Cystic fibrosis (CF) patients (diagnosis confirmed by sweat test)
2. Age greater than 6 years - 60 years, either sex
3. Newly acquired MRSA

Exclusion Criteria

1. Lung transplantation
2. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eradication of MRSA from the respiratory samples during and after completion of eradication

Secondary Outcome Measures

Name	Time	Method
<br> 1. Lung function values (including LCI)<br> 2. Clinical status<br>